1. Home
  2. PSIG vs LYRA Comparison

PSIG vs LYRA Comparison

Compare PSIG & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSIG
  • LYRA
  • Stock Information
  • Founded
  • PSIG 1993
  • LYRA 2005
  • Country
  • PSIG Hong Kong
  • LYRA United States
  • Employees
  • PSIG N/A
  • LYRA N/A
  • Industry
  • PSIG
  • LYRA Medical/Dental Instruments
  • Sector
  • PSIG
  • LYRA Health Care
  • Exchange
  • PSIG NYSE
  • LYRA Nasdaq
  • Market Cap
  • PSIG 11.3M
  • LYRA 11.8M
  • IPO Year
  • PSIG N/A
  • LYRA 2020
  • Fundamental
  • Price
  • PSIG $0.45
  • LYRA $0.11
  • Analyst Decision
  • PSIG
  • LYRA Hold
  • Analyst Count
  • PSIG 0
  • LYRA 4
  • Target Price
  • PSIG N/A
  • LYRA $1.25
  • AVG Volume (30 Days)
  • PSIG 334.7K
  • LYRA 845.3K
  • Earning Date
  • PSIG 12-12-2024
  • LYRA 03-13-2025
  • Dividend Yield
  • PSIG N/A
  • LYRA N/A
  • EPS Growth
  • PSIG N/A
  • LYRA N/A
  • EPS
  • PSIG N/A
  • LYRA N/A
  • Revenue
  • PSIG $112,317,226.00
  • LYRA $1,534,000.00
  • Revenue This Year
  • PSIG N/A
  • LYRA N/A
  • Revenue Next Year
  • PSIG N/A
  • LYRA $519.89
  • P/E Ratio
  • PSIG N/A
  • LYRA N/A
  • Revenue Growth
  • PSIG N/A
  • LYRA N/A
  • 52 Week Low
  • PSIG $0.38
  • LYRA $0.11
  • 52 Week High
  • PSIG $4.20
  • LYRA $5.83
  • Technical
  • Relative Strength Index (RSI)
  • PSIG N/A
  • LYRA 19.74
  • Support Level
  • PSIG N/A
  • LYRA $0.14
  • Resistance Level
  • PSIG N/A
  • LYRA $0.13
  • Average True Range (ATR)
  • PSIG 0.00
  • LYRA 0.02
  • MACD
  • PSIG 0.00
  • LYRA -0.01
  • Stochastic Oscillator
  • PSIG 0.00
  • LYRA 2.74

About PSIG PS INTERNATIONAL GROUP LTD

PS International Group Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports, and local transportation and warehousing-related services such as repackaging, labeling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing to meet the requirement of customers.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: